I-FABP and L-FABP are early markers for abdominal injury with limited prognostic value for secondary organ failures in the post-traumatic course

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 5, 2015, Pages 771-780

  Voth, Maika ^b   Holzberger, Sebastian ^b   Auner, Birgit ^b   Henrich, Dirk ^b   Marzi, Ingo ^b   Relja, Borna ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

biomarkers; emergency; organ failure; small fatty acid binding protein (FABP); trauma

Indexed keywords

CREATININE; FATTY ACID BINDING PROTEIN; BIOLOGICAL MARKER; FABP1 PROTEIN, HUMAN; FABP2 PROTEIN, HUMAN;

ABDOMINAL INJURY; ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; MULTIPLE TRAUMA; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEPSIS; URINARY TRACT INFECTION; BLOOD; COMPLICATION; MIDDLE AGED;

ABDOMINAL INJURIES; ADULT; AGED; BIOMARKERS; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROGNOSIS; SEPSIS;

EID: 84928045391     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0354     Document Type: Article

References (69)

1. Nast-Kolb D, Waydhas C, Kastl S, Duswald KH, Schweiberer L. The role of an abdominal injury in follow-up of polytrauma patients. Chirurg 1993;64:552-9.
2. Walcher F, Kortum S, Kirschning T, Weihgold N, Marzi I. Optimized management of polytraumatized patients by prehospital ultrasound. Unfallchirurg 2002;105:986-94.
3. Relja B, Szermutzky M, Henrich D, Maier M, de Haan JJ, Lubbers T, et al. Intestinal-FABP and liver-FABP: novel markers for severe abdominal injury. Acad Emerg Med 2010;17:729-35.
4. Blaivas M, Sierzenski P, Theodoro D. Significant hemoperitoneum in blunt trauma victims with normal vital signs and clinical examination. Am J Emerg Med 2002;20:218-21.
5. Helling TS, Wilson J, Augustosky K. The utility of focused abdominal ultrasound in blunt abdominal trauma: a reappraisal. Am J Surg 2007;194:728-32.
6. Davis JW, Hoyt DB, Mackersie RC, McArdle MS. Complications in evaluating abdominal trauma: diagnostic peritoneal lavage versus computerized axial tomography. J Trauma 1990;30:1506-9.
7. Krupnick AS, Teitelbaum DH, Geiger JD, Strouse PJ, Cox CS, Blane CE, et al. Use of abdominal ultrasonography to assess pediatric splenic trauma. Potential pitfalls in the diagnosis. Ann Surg 1997;225:408-14.
8. Liu M, Lee CH, P'eng FK. Prospective comparison of diagnostic peritoneal lavage, computed tomographic scanning, and ultrasonography for the diagnosis of blunt abdominal trauma. J Trauma 1993;35:267-70.
9. Pal JD, Victorino GP. Defining the role of computed tomography in blunt abdominal trauma: use in the hemodynamically stable patient with a depressed level of consciousness. Arch Surg 2002;137:1029-32.
10. Scaglione M, de Lutio di CE, Scialpi M, Merola S, Diettrich AI, Lombardo P, et al. Blunt trauma to the gastrointestinal tract and mesentery: is there a role for helical CT in the decision-making process? Eur J Radiol 2004;50:67-73.
11. Marzi I, Rose S. Praxisbuch polytrauma. Stuttgart: Deutscher Ärzte-Verlag, 2012.
12. Enderson BL, Maull KI. Missed injuries. The trauma surgeon's nemesis. Surg Clin North Am 1991;71:399-418.
13. Fakhry SM, Brownstein M, Watts DD, Baker CC, Oller D. Relatively short diagnostic delays (<8 hours) produce morbidity and mortality in blunt small bowel injury: an analysis of time to operative intervention in 198 patients from a multicenter experience. J Trauma 2000;48:408-14.
14. Osborn TM, Tracy JK, Dunne JR, Pasquale M, Napolitano LM. Epidemiology of sepsis in patients with traumatic injury. Crit Care Med 2004;32:2234-40.
15. Tiwari A, Myint F, Hamilton G. Recognition and management of abdominal compartment syndrome in the United Kingdom. Intensive Care Med 2006;32:906-9.
16. Watts DD, Fakhry SM. Incidence of hollow viscus injury in blunt trauma: an analysis from 275,557 trauma admissions from the East multi-institutional trial. J Trauma 2003;54:289-94.
17. Shebrain S, Zelada J, Lipsky AM, Putnam B. Mesenteric injuries after blunt abdominal trauma: delay in diagnosis and increased morbidity. Am Surg 2006;72:955-61.
18. Marik PE, Flemmer M. The immune response to surgery and trauma: implications for treatment. J Trauma Acute Care Surg 2012;73:801-8.
19. Tsukamoto T, Chanthaphavong RS, Pape HC. Current theories on the pathophysiology of multiple organ failure after trauma. Injury 2010;41:21-6.
20. Baumgart DC, Dignass AU. Intestinal barrier function. Curr Opin Clin Nutr Metab Care 2002;5:685-94.
21. Berg RD. Bacterial translocation from the gastrointestinal tract. Adv Exp Med Biol 1999;473:11-30.
22. Thuijls G, de Haan JJ, Derikx JP, Daissormont I, Hadfoune M, Heineman E, et al. Intestinal cytoskeleton degradation precedes tight junction loss following hemorrhagic shock. Shock 2009;31:164-9.
23. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992;216:117-34.
24. Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract. The 'undrained abscess' of multiple organ failure. Ann Surg 1993;218:111-9.
25. Pfeifer R, Tarkin IS, Rocos B, Pape HC. Patterns of mortality and causes of death in polytrauma patients - has anything changed? Injury 2009;40:907-11.
26. Cook R, Cook D, Tilley J, Lee K, Marshall J. Multiple organ dysfunction: baseline and serial component scores. Crit Care Med 2001;29:2046-50.
27. DeCamp MM, Demling RH. Posttraumatic multisystem organ failure. J Am Med Assoc 1988;260:530-4.
28. Vincent JL, Moreno R, Takala J, Willatts S, De MA, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-10.
29. Minne L, Abu-Hanna A, de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: a systematic review. Crit Care 2008;12:R161.
30. Nogueira LS, Sousa RM, Domingues CA. Severity of trauma victims admitted in intensive care units: comparative study among different indexes. Rev Lat Am Enfermagem 2009;17:1037-42.
31. Rhodes A, Moreno RP, Metnitz B, Hochrieser H, Bauer P, Metnitz P. Epidemiology and outcome following post-surgical admission to critical care. Intensive Care Med 2011;37:1466-72.
32. Glatz JF, van der Vusse GJ. Cellular fatty acid-binding proteins: their function and physiological significance. Prog Lipid Res 1996;35:243-82.
33. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005;352:15-35.
34. Banaszak L, Winter N, Xu Z, Bernlohr DA, Cowan S, Jones TA. Lipid-binding proteins: a family of fatty acid and retinoid transport proteins. Adv Protein Chem 1994;45:89-151.
35. Flower DR. The lipocalin protein family: structure and function. Biochem J 1996;318:1-14.
36. Ockner RK, Manning JA, Poppenhausen RB, Ho WK. A binding protein for fatty acids in cytosol of intestinal mucosa, liver, myocardium, and other tissues. Science 1972;177:56-8.
37. Schachtrup C, Scholzen TE, Grau V, Luger TA, Sorg C, Spener F, et al. L-FABP is exclusively expressed in alveolar macrophages within the myeloid lineage: evidence for a PPARalpha-independent expression. Int J Biochem Cell Biol 2004;36:2042-53.
38. Pelsers MM, Namiot Z, Kisielewski W, Namiot A, Januszkiewicz M, Hermens WT, et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem 2003;36:529-35.
39. Edelson MB, Sonnino RE, Bagwell CE, Lieberman JM, Marks WH, Rozycki HJ. Plasma intestinal fatty acid binding protein in neonates with necrotizing enterocolitis: a pilot study. J Pediatr Surg 1999;34:1453-7.
40. Guthmann F, Borchers T, Wolfrum C, Wustrack T, Bartholomaus S, Spener F. Plasma concentration of intestinal- and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates. Mol Cell Biochem 2002;239:227-34.
41. Kanda T, Fujii H, Tani T, Murakami H, Suda T, Sakai Y, et al. Intestinal fatty acid-binding protein is a useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 1996;110:339-43.
42. Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H. Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis. Clin Nephrol 2006;65:1-6.
43. Doi K, Noiri E, Maeda-Mamiya R, Ishii T, Negishi K, Hamasaki Y, et al. Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. Crit Care Med 2010;38:2037-42.
44. Noiri E, Doi K, Negishi K, Tanaka T, Hamasaki Y, Fujita T, et al. Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury. Am J Physiol Renal Physiol 2009;296:F669-79.
45. Derikx JP, Poeze M, van Bijnen AA, Buurman WA, Heineman E. Evidence for intestinal and liver epithelial cell injury in the early phase of sepsis. Shock 2007;28:544-8.
46. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ 2007;85:867-72.
47. The Abbreviated Injury Scale, 1990 Revision, Update 98, 1998.
48. Association for the Advancement of Automotive Medicine. The Abbreviated Injury Scale 2005. Des Plains, IL: AAAM, 2005.
49. Baker SP, O'Neill B, Haddon W Jr., Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974;14:187-96.
50. Reinhart K, Brunkhorst F, Bone H, Gerlach H, Grundling M, Kreymann G, et al. Diagnosis and therapy of sepsis. Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine. Internist (Berl) 2006;47:356.
51. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. J Am Med Assoc 1993;270:2957-63.
52. Brattstrom O, Granath F, Rossi P, Oldner A. Early predictors of morbidity and mortality in trauma patients treated in the intensive care unit. Acta Anaesthesiol Scand 2010;54:1007-17.
53. Probst C, Zelle BA, Sittaro NA, Lohse R, Krettek C, Pape HC. Late death after multiple severe trauma: when does it occur and what are the causes? J Trauma 2009;66:1212-7.
54. Cronk DR, Houseworth TP, Cuadrado DG, Herbert GS, McNutt PM, Azarow KS. Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction. Curr Surg 2006;63:322-5.
55. Kanda T, Nakatomi Y, Ishikawa H, Hitomi M, Matsubara Y, Ono T, et al. Intestinal fatty acid-binding protein as a sensitive marker of intestinal ischemia. Dig Dis Sci 1992;37:1362-7.
56. Monbaliu D, de Vries B, Crabbe T, van Heum E, Verwaest C, Roskams T, et al. Liver fatty acid-binding protein: an early and sensitive plasma marker of hepatocellular damage and a reliable predictor of graft viability after liver transplantation from non-heart-beating donors. Transplant Proc 2005;37:413-6.
57. Pelsers MM, Morovat A, Alexander GJ, Hermens WT, Trull AK, Glatz JF. Liver fatty acid-binding protein as a sensitive serum marker of acute hepatocellular damage in liver transplant recipients. Clin Chem 2002;48:2055-7.
58. Poirier H, Niot I, Degrace P, Monnot MC, Bernard A, Besnard P. Fatty acid regulation of fatty acid-binding protein expression in the small intestine. Am J Physiol 1997;273:G289-95.
59. Derikx JP, Vreugdenhil AC, Van den Neucker AM, Grootjans J, van Bijnen AA, Damoiseaux JG, et al. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP. J Clin Gastroenterol 2009;43:727-33.
60. Lieberman JM, Sacchettini J, Marks C, Marks WH. Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. Surgery 1997;121:335-42.
61. Lachmann RA, Werchan S, Schachtrup C, Haitsma JJ, Spener F, Lachmann B. Liver-type fatty acid binding protein in serum and broncho-alveolar lavage in a model of acute respiratory failure because of surfactant depletion - a possible marker for lung damage? Clin Physiol Funct Imaging 2006;26:371-5.
62. de Haan JJ, Lubbers T, Derikx JP, Relja B, Henrich D, Greve JW, et al. Rapid development of intestinal cell damage following severe trauma: a prospective observational cohort study. Crit Care 2009;13:R86.
63. Jones AE, Aborn LS, Kline JA. Severity of emergency department hypotension predicts adverse hospital outcome. Shock 2004;22:410-4.
64. MacFie J, O'Boyle C, Mitchell CJ, Buckley PM, Johnstone D, Sudworth P. Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 1999;45: 223-8.
65. Poeze M, Ramsay G, Buurman WA, Greve JW, Dentener M, Takala J. Increased hepatosplanchnic inflammation precedes the development of organ dysfunction after elective high-risk surgery. Shock 2002;17:451-8.
66. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med 2001;29(7 Suppl):S109-16.
67. Feng Z, Zhang SW. A study of urine lactulose/mannitol ratio and intestinal fatty acid binding protein as the indexes of intestinal damage in sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2009;21:470-3.
68. Negishi K, Noiri E, Doi K, Maeda-Mamiya R, Sugaya T, Portilla D, et al. Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury. Am J Pathol 2009;174:1154-9.
69. Kamijo A, Sugaya T, Hikawa A, Yamanouchi M, Hirata Y, Ishimitsu T, et al. Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem 2006;284:175-82.